FDA approval of Tecvayli, from Johnson & Johnson subsidiary Janssen Biotech, makes it the newest therapy that treats multiple myeloma by targeting the cancer protein BCMA. Though this off-the-shelf drug offers patients a more convenient dosing option, it comes with similar complication risks as other biologics approved for this type of blood cancer.
Gilead Sciences is a leader in the field of virology treatments. As VP of clinical research for hepatitis, respiratory and emerging viruses at Gilead, Anu Osinusitalked about the pharma company's work in HIV and hepatitis and how her personal background informed her team's work in developing a Covid-19 treatment.
By Katie Adams Wednesday, October 26, 2022 6:56 PM
Kaiser Permanente is a couple months into a first-of-its kind community program focused on helping Americans build their credit. Having no credit or bad credit is a major barrier to financial mobility, which is often a necessity to living a healthy life.
By Marissa Plescia Wednesday, October 26, 2022 6:02 PM
The top strategies to support mental health issues are offering coverage for telebehavioral health services, providing onsite or virtual employee assistance programs and providing access to digital behavioral health support, a survey of 455 employers found.
By Katie Adams Wednesday, October 26, 2022 5:56 PM
A new report revealed key trends about patient preferences, including information about how they prefer to schedule appointments and choose providers. The trends uncovered in the report lend themselves to some key recommendations that healthcare providers should consider, such as improving post-ER communication and putting a greater emphasis on online reputation management.
By Marissa Plescia Wednesday, October 26, 2022 5:48 PM
A recent study found that AI is equal to humans in identifying red-flag language in text messaging. While some clinicians may be worried about being replaced by AI, experts said the technology is only a tool to support their work.
By Rohit Malik Wednesday, October 26, 2022 2:00 PM
Realizing the value of cloud, life sciences companies and leading pharma organizations across the world's R&D teams are increasing operations to collaborate and drive clinical trials.
The industry faces challenges from inflation to labor shortages, according to an annual report from EY. However, there are grounds for optimism and areas to focus on, such as patching up supply chains.
By Amanda Wheeler Wednesday, October 26, 2022 9:30 AM
Patient privacy is a winner of the transition to GA4. Making the switch to the new analytics platform will allow your organization to more easily adhere to HIPAA regulations, working with other patient privacy standards to keep patient data safe and secure.
By Mark Goldstone Wednesday, October 26, 2022 9:00 AM
Consumer-led healthcare will change patient care pathways, driving the industry to grow and collaborate in new ways, both with patients around their own health and with partners and innovators.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments